Viewing Study NCT05066802


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2025-12-26 @ 2:35 AM
Study NCT ID: NCT05066802
Status: UNKNOWN
Last Update Posted: 2021-10-04
First Post: 2021-09-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module